Deal facts
- Buyer
- BC PARTNERS
- Target
- ACS DOBFAR
- Deal value
- Not disclosed
- Announced
- 8 October 2026
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
BC PARTNERS has agreed to acquire ACS DOBFAR in a strategic acquisition within the healthcare sector. The transaction was announced on 8 October 2026. No specific financial details, including the total deal value or the form of consideration, have been disclosed in the available records. Consequently, the precise monetary terms of the agreement remain unknown to the public. The parties involved have not provided further clarification on the structure of the payment or any additional components of the deal. This acquisition represents a significant move in the healthcare industry, although the specific strategic rationale has not been detailed in the initial announcement. The lack of reported figures limits the ability to assess the scale of the transaction relative to other recent deals in the sector.
The current status of the transaction is in review. No completion date has been confirmed, and the deal has not yet closed. Regulatory approvals and other standard conditions precedent may still be required before the acquisition can be finalized. Stakeholders are advised to monitor official channels for updates regarding the progress of the review process. Until further notice, the transaction remains pending, with no indication of immediate closure. The absence of a reported completion date suggests that the process is still in its early stages of evaluation and approval.
Deal timeline
1 update- CMA invitation to comment
BC PARTNERS / ACS DOBFAR / INFORLIFE
FormalInvestigationPhase1Merger BC PARTNERS / ACS DOBFAR / INFORLIFE
EU DG COMP
For business owners
What would selling your own business involve?
Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.
Guides are free to read. Free tools require email access; indicative results are not professional advice.
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Bolt Biotherapeutics, Inc. to acquire Prana Therapies, Inc.
Bolt Biotherapeutics, Inc. completed its acquisition of Prana Therapies, Inc. on October 23, 2026, under an Agreement and Plan of Merger dated the same day. The deal was…
- Buyer
- Bolt Biotherapeutics, Inc.
- Target
- Prana Therapies, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Janel Corporation to acquire EnCor Biotechnology Inc.
Janel Corporation, through its wholly owned subsidiary Antibodies Incorporated, completed the acquisition of EnCor Biotechnology Inc. on October 20, 2026. Under the Purc…
- Buyer
- Janel Corporation
- Target
- EnCor Biotechnology Inc.
- Deal value
- USD 17,000,000
- Deal type
- strategic acquisition
Cencora, Inc. to acquire American Oncology Network, Inc.
Cencora, Inc. has agreed to acquire American Oncology Network, Inc. in a strategic acquisition within the healthcare sector. Both the buyer and the target are based in t…
- Buyer
- Cencora, Inc.
- Target
- American Oncology Network, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
TCGX Acquisition Corp. to acquire TriGemX Bio, Inc.
TCGX Acquisition Corp. has agreed to acquire TriGemX Bio, Inc. in a strategic transaction valued at 361 million US dollars. The deal, announced on 18 October 2026, invol…
- Buyer
- TCGX Acquisition Corp.
- Target
- TriGemX Bio, Inc.
- Deal value
- USD 361,000,000
- Deal type
- strategic acquisition
Buyer history
BC PARTNERS
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive